Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

The policy of billing for secure messages changes patient expectations and can impact the patient-physician relationship.

During the COVID-19 public health emergency period, excess mortality occurred in all racial and ethnic groups, but disparities were observed.

Food allergy-related distress is common and varies across countries, according to study findings published in the October issue of Allergy.

Vaccination for influenza, SARS-CoV-2, and respiratory syncytial virus is less likely with an increasing social vulnerability index and Black race.

Interim findings show clesrovimab has a similar safety profile to palivizumab. Clesrovimab, an investigational respiratory syncytial virus (RSV) fusion glycoprotein neutralizing monoclonal antibody, ...

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

AI-generated responses to patient portal messages may improve workflow for nurses but not for other health care workers, a new study suggests.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

Despite having a worse clinicopathogic profile, patients with CHNM had a better response to ICI therapy when compared with patients with CMOS.